Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 20,000 shares at $80.02 ($1.6M) on 2025-06-27, disclosed to the SEC on 2025-07-01.
Scheduled sale ($1.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |